Tech Company Financing Transactions
Amethyst Radiotherapy Funding Round
Ares Management invested in a $325.2 million funding round for Amethyst Radiotherapy. The round was announced on 7/3/2024.
Transaction Overview
Company Name
Announced On
7/3/2024
Transaction Type
Venture Equity
Amount
$325,220,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Strawinskylaan 3127
Amsterdam, 1077 ZX
The Netherlands
Amsterdam, 1077 ZX
The Netherlands
Phone
Undisclosed
Email Address
Overview
In order to help patients fight cancer, we believe in the combination of high-quality treatments delivered by cancer experts and a comprehensive patient-centred care. Our values embody patient-centric care, leveraging state-of-the-art technology, fostering the most supportive environment for healthcare professionals, serving as a public healthcare partner throughout Europe, and uniting a European-native group with local expertise to form an Alliance of medical excellence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stéphane Carré
Chief Financial Officer
Andrew Nelson
Chief Information Officer
Tomasz Snoch
Chief Marketing Officer
Sophie Ward
Browse more venture capital transactions:
Prev: 7/3/2024: Nycrypto Labs venture capital transaction
Next: 7/3/2024: Trever venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs